Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use NOVOLOG MIX 70/30 safely and effectively. See full prescribing information for NOVOLOG MIX 70/30. NOVOLOG® MIX 70/30 (insulin aspart protamine and insulin aspart) injectable suspension, for subcutaneous useInitial U.S. Approval: 2001
Medication labelWhy this: Advisory · dailymed-prescription
NOVOLOG MIX 70/30 is a mixture of insulin aspart protamine and insulin aspart indicated to improve glycemic control in adult patients with diabetes mellitus. Limitations of Use: •NOVOLOG MIX 70/30 is not recommended for the treatment of diabetic ketoacidosis. •The proportions of rapid-acting and long-acting insulins in NOVOLOG MIX 70/30 are fixed and do not allow for basal versus prandial dose adjustments.
- generic_name
- insulin aspart
- product_names
- insulin aspart
- ndc
- 0169-3685, 0169-3685-12, 0169-3685-92, 0169-3696, 0169-3696-19, 0169-3696-97, 0169-3696-90, 0169-3696-98, 0169-2200, 0169-2200-11, 0169-2201, 0169-2201-25
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en